ClinicalTrials.Veeva

Menu

LIA vs. LIA + ACB-iPACK Block for Total Knee Arthroplasty

W

Women's College Hospital

Status

Begins enrollment in 6 months

Conditions

Nerve Block
Neuromuscular Blockade

Treatments

Procedure: Local infiltration analgesia
Procedure: Ultrasound-guided adductor canal block

Study type

Interventional

Funder types

Other

Identifiers

NCT04808947
LIA vs. LIA + ACB-iPACK block

Details and patient eligibility

About

LIA is the mainstay of postoperative analgesia in patients having knee arthroplasty. The combination of ACB-iPACK blocks has also been proposed as an effective analgesic modality for total knee arthroplasty. However, whether combining these two modalities yields any important incremental analgesic benefit remains unclear. The investigators hypothesized that the addition of ACB and iPACK blocks to LIA will yield clinically important analgesic benefits compared to LIA alone in patients having total knee arthroplasty.

Full description

LIA is the mainstay of postoperative analgesia in patients having knee arthroplasty. Performed by surgeons, LIA provides effective postoperative pain relief and reduces opioid requirements. Similar analgesic benefits have also been attributed to adductor canal and iPACK blocks, which partially block sensory innervation to the knee and its posterior capsule. Performed by anesthesiologist preoperatively, these blocks have also been incorporated into the care standard in numerous centers. However, it is not clear whether adding the adductor canal and iPACK blocks yields any incremental analgesic benefits. The investigators aimed to evaluate the benefits of adding adductor canal and iPACK blocks to LIA in patients having total knee arthroplasty.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. ASA classification I-III
  2. BMI < 35 kg/m2
  3. Having elective unilateral total knee arthroplasty

Exclusion criteria

  1. Bilateral knee surgery.
  2. Pre-existing neurological deficit or peripheral neuropathy in the lower the lower limbs
  3. Severe, poorly controlled cardiac conditions, significant arrhythmias, severe valvular heart diseases
  4. Severe, poorly controlled respiratory conditions (severe COPD, severe interstitial lung disease, severe / poorly controlled asthma)
  5. Contraindication to regional anesthesia (e.g. bleeding diathesis, coagulopathy, sepsis, infection at the site of potential needle puncture on the posterior chest)
  6. Patient refusal
  7. Chronic pain disorder
  8. Chronic opioid use (≥30 mg oxycodone / day)
  9. Contraindication (or allergy) to a component of multi-modal analgesia protocol
  10. Allergy to amide local anesthetics used in nerve blocks
  11. Contraindications to spinal anesthesia
  12. Significant psychiatric disorder that would preclude objective study assessment
  13. Pregnancy
  14. Inability to provide informed consent

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 2 patient groups

Local infiltration analgesia
Experimental group
Description:
Patients in this group will receive LIA intraoperatively, as per institutional standard. The injected solution will be comprised of 100cc Ropiv 2%, + Ketorolac 30 mg + Epinephrine 25 ug.
Treatment:
Procedure: Local infiltration analgesia
Local infiltration analgesia + ACB-iPACK block
Active Comparator group
Description:
Patients in this group will receive LIA intraoperatively, as per institutional standard. The injected solution will be comprised of 100cc Ropiv 2%, + Ketorolac 30 mg + Epinephrine 25 ug. Patients in this group will also receive preoperative nerve blocks under ultrasound guidance. These will include: 1. Adductor canal block with 0.5% Ropivacaine w/epi 20 mL 2. iPack block with 0.25% Ropivacaine w/epi 10 mL
Treatment:
Procedure: Ultrasound-guided adductor canal block
Procedure: Local infiltration analgesia

Trial contacts and locations

0

Loading...

Central trial contact

Didem Bozak

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems